Company: SVV
Filing Date: 2025-05-16
Form Type: 424B5
Source: 0001193125-25-121233
Chunk: 35

Company: Savers Value Village, Inc.
Filing Date: 2025-05-16
Form: 424B5
Chunk 35
---
writers and selling group members that may make Internet distributions on the same basis as other allocations. We have agreed that, for a period of 75 days after the date of this prospectus supplement, we will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, or submit to, or file with, the SEC a registration statement under the Securities Act relating to, any shares of our common stock or any securities convertible into or exercisable or exchangeable for our common stock, or publicly disclose the intention to undertake any of the foregoing, or (ii) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of our common stock or any such other securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of common stock or such other securities, in cash or otherwise, without the prior written consent of J.P. Morgan Securities LLC and Jefferies LLC, other than the shares of our common stock to be sold in this offering. The restrictions described above do not apply to certain transactions, including (i) the issuance of shares of our common stock or securities convertible into or exercisable for shares of our common stock pursuant to the conversion or exchange of convertible or exchangeable securities or the exercise of warrants or options (including net exercise) or the settlement of RSUs (including net settlement), in each case outstanding on the date of the underwriting agreement and described in this prospectus supplement and the accompanying prospectus; (ii) grants of stock options, stock awards, restricted stock, RSUs, or other equity awards and the issuance of shares of our common stock or securities convertible into or exercisable or exchangeable for shares of our common stock (whether upon the exercise of stock options or otherwise) to our employees, officers, directors, advisors, or consultants pursuant to the terms of an equity compensation plan in effect as of the closing of this offering and described in this prospectus supplement and the accompanying prospectus, provided that such recipients enter into a lock-upagreement with the underwriters; (iii) the issuance of up to 10% of the outstanding shares of our common stock or securities convertible into, exercisable for, or which are otherwise exchangeable for shares of our common stock in acquisitions or other strategic transactions, provided that